Tower Research Capital LLC (TRC) - AUDENTES THERAPEUTICS INC ownership

AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AUDENTES THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$68,000
+871.4%
2,438
+1137.6%
0.01%
Q2 2019$7,000
-22.2%
197
-50.8%
0.00%
-100.0%
Q4 2018$9,000
-25.0%
400
+37.5%
0.00%0.0%
Q3 2018$12,000
-85.7%
291
-90.3%
0.00%
-85.7%
Q3 2017$84,000
+4100.0%
2,985
+2770.2%
0.01%
Q2 2017$2,0000.0%104
+4.0%
0.00%
Q1 2017$2,000
-75.0%
100
-75.7%
0.00%
-100.0%
Q4 2016$8,000
+14.3%
412
+11.4%
0.00%0.0%
Q3 2016$7,0003700.00%
Other shareholders
AUDENTES THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 767,502$45,927,00023.65%
Chicago Capital Management, LLC 250,401$14,984,00012.57%
Foresite Capital Management III, LLC 233,067$13,947,0007.82%
Partner Investment Management, L.P. 17,795$1,065,0007.65%
RAMIUS ADVISORS LLC 220,784$13,212,0005.68%
Beryl Capital Management LLC 550,426$32,937,0005.31%
GARDNER LEWIS ASSET MANAGEMENT L P 647,460$38,744,0005.28%
FNY Investment Advisers, LLC 278,861$16,687,0005.17%
WHITE SQUARE CAPITAL LLP 112,500$6,732,0004.87%
Casdin Capital, LLC 860,000$51,462,0004.73%
View complete list of AUDENTES THERAPEUTICS INC shareholders